Learn more about us
Infinity Treatment Centers of America are a group of REMS certified SPRAVATO® Treatment Centers built specifically for patients with Treatment Resistant Depression (TRD). A patient with TRD is commonly defined someone diagnosed with major depressive disorder who does not respond adequately to a course of antidepressant medications over an adequate period of time. It is not unusual that patients fail to get better after trying multiple antidepressant medications. SPRAVATO esketamine may be the answer you are looking for.
REMS is the US Food and Drug Administration’s RISK EVALUATION AND MITIGATION STRATEGY program for the administration of special drugs that may have adverse side effects. REMS sets the standards of safety which Infinity Treatment Centers of America must follow to ensure the highest standard of care. Our trained doctors and clinical personnel have your best interests and wellness as the highest priority. At Infinity Treatment Centers of America, we strive to help you be Forever Better.
What is SPRAVATO®?
SPRAVATO® is the first new drug approved for depression by the Federal Drug Administration (FDA) since Prozac. SPRAVATO esketamine nasal spray is indicated for patients suffering from Treatment Resistant Depression (TRD) and Major Depressive Disorder (MDD) with suicidal ideation. If you are currently diagnosed with depression and have not responded well to at least two different oral antidepressants over an extended period of time you may qualify for SPRAVATO®. Ask your healthcare provider about SPRAVATO® and contact us.